REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q1 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2 | -33.3% | 146 | 0.0% | 0.00% | – |
Q2 2023 | $3 | 0.0% | 146 | 0.0% | 0.00% | – |
Q1 2023 | $3 | 0.0% | 146 | 0.0% | 0.00% | – |
Q4 2022 | $3 | -99.9% | 146 | 0.0% | 0.00% | – |
Q3 2022 | $4,000 | 0.0% | 146 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | -20.0% | 146 | 0.0% | 0.00% | – |
Q1 2022 | $5,000 | 0.0% | 146 | 0.0% | 0.00% | – |
Q4 2021 | $5,000 | -16.7% | 146 | 0.0% | 0.00% | – |
Q3 2021 | $6,000 | +100.0% | 146 | +73.8% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 84 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | 0.0% | 84 | +20.0% | 0.00% | – |
Q4 2020 | $3,000 | -50.0% | 70 | -66.3% | 0.00% | – |
Q3 2020 | $6,000 | -14.3% | 208 | 0.0% | 0.00% | – |
Q2 2020 | $7,000 | 0.0% | 208 | 0.0% | 0.00% | – |
Q1 2020 | $7,000 | -22.2% | 208 | 0.0% | 0.00% | – |
Q4 2019 | $9,000 | +12.5% | 208 | -10.3% | 0.00% | – |
Q3 2019 | $8,000 | -33.3% | 232 | 0.0% | 0.00% | – |
Q2 2019 | $12,000 | -7.7% | 232 | 0.0% | 0.00% | – |
Q1 2019 | $13,000 | +85.7% | 232 | +34.9% | 0.00% | – |
Q4 2018 | $7,000 | -46.2% | 172 | 0.0% | 0.00% | – |
Q3 2018 | $13,000 | +8.3% | 172 | 0.0% | 0.00% | – |
Q2 2018 | $12,000 | +140.0% | 172 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | – | 172 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 1,459,128 | $110,164,000 | 6.60% |
ArchPoint Investors | 224,187 | $16,926,000 | 4.60% |
Redmile Group, LLC | 1,656,065 | $125,033,000 | 3.85% |
WS MANAGEMENT LLLP | 954,812 | $72,088,000 | 2.37% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 342,000 | $25,821,000 | 1.19% |
Perceptive Advisors | 470,672 | $35,536,000 | 0.95% |
Pier Capital, LLC | 94,492 | $7,134,000 | 0.90% |
Ipswich Investment Management Co., Inc. | 29,932 | $2,260,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 275,000 | $20,763,000 | 0.74% |
Timpani Capital Management LLC | 27,835 | $2,102,000 | 0.61% |